ATE444299T1 - Neue boronatester - Google Patents

Neue boronatester

Info

Publication number
ATE444299T1
ATE444299T1 AT02707083T AT02707083T ATE444299T1 AT E444299 T1 ATE444299 T1 AT E444299T1 AT 02707083 T AT02707083 T AT 02707083T AT 02707083 T AT02707083 T AT 02707083T AT E444299 T1 ATE444299 T1 AT E444299T1
Authority
AT
Austria
Prior art keywords
new
boronate esters
pitavastatin
cerivastatin
rosuvastatin
Prior art date
Application number
AT02707083T
Other languages
English (en)
Inventor
Tom Puthiaprampil
Sumithra Srinath
Madhavan Sridharan
Sambasivam Ganesh
Original Assignee
Biocon Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocon Ltd filed Critical Biocon Ltd
Application granted granted Critical
Publication of ATE444299T1 publication Critical patent/ATE444299T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrrole Compounds (AREA)
AT02707083T 2002-02-25 2002-02-25 Neue boronatester ATE444299T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2002/000032 WO2003070733A1 (en) 2002-02-25 2002-02-25 Novel boronate esters

Publications (1)

Publication Number Publication Date
ATE444299T1 true ATE444299T1 (de) 2009-10-15

Family

ID=27742233

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02707083T ATE444299T1 (de) 2002-02-25 2002-02-25 Neue boronatester

Country Status (21)

Country Link
US (2) US7301046B2 (de)
EP (1) EP1478650B1 (de)
JP (1) JP4139334B2 (de)
KR (1) KR100598079B1 (de)
AT (1) ATE444299T1 (de)
AU (1) AU2002241235B2 (de)
BR (1) BR0215602A (de)
CA (1) CA2475586C (de)
CZ (1) CZ2004863A3 (de)
DE (1) DE60233899D1 (de)
DK (1) DK1478650T3 (de)
ES (1) ES2332881T3 (de)
HR (1) HRP20040888B1 (de)
HU (1) HUP0500125A3 (de)
IL (1) IL163333A (de)
NO (1) NO20043223L (de)
NZ (1) NZ534688A (de)
PT (1) PT1478650E (de)
RO (1) RO122095B1 (de)
SK (1) SK288093B6 (de)
WO (1) WO2003070733A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011120D0 (en) * 2000-05-09 2000-06-28 Avecia Ltd Process
NL1015744C2 (nl) * 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
US7135978B2 (en) 2001-09-14 2006-11-14 Calypso Medical Technologies, Inc. Miniature resonating marker assembly
EP1323717A1 (de) * 2001-12-27 2003-07-02 Dsm N.V. Prozess für die Herstellung von 2-(6-Substituierten-1,3-Dioxan-4-yl) Essigsäure Derivaten
BR0215602A (pt) 2002-02-25 2004-12-07 Biocon Ltd ésteres de boronato
WO2008091288A2 (en) * 2006-07-19 2008-07-31 Board Of Trustees Of Michigan State University Microbial synthesis of d-1,2,4-butanetriol
WO2008042876A2 (en) 2006-10-02 2008-04-10 Codexis, Inc. Compositions and methods for producing stereoisomerically pure statins and synthetic intermediates therefor
KR100933172B1 (ko) 2007-11-30 2009-12-21 씨제이제일제당 (주) 아토르바스타틴 칼슘염의 개선된 제조방법
KR101339648B1 (ko) * 2012-05-10 2013-12-09 (주) 에프엔지리서치 신규한 아토바스타틴 중간체 및 이를 이용한 아토바스타틴의 제조 방법
KR101292743B1 (ko) * 2012-05-17 2013-08-02 (주) 에프엔지리서치 신규한 스타틴 중간체 및 이를 이용한 피타바스타틴, 로수바스타틴, 세리바스타틴 및 플루바스타틴의 제조 방법
KR101528359B1 (ko) * 2013-04-24 2015-06-15 (주) 성운파마코피아 스타틴 화합물 제조를 위한 신규한 보로네이트 에테르 화합물, 그 제조방법 및 상기 보로네이트 에테르 화합물을 이용한 스타틴 화합물 제조방법
CN108033899B (zh) * 2017-12-06 2020-04-10 浙江科技学院 一种(r)-6-氰基-5-羟基-3-羰基己酸叔丁酯的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474034A (en) 1982-09-23 1984-10-02 Avery Jr Richard J Refrigerant accumulator and charging apparatus and method for vapor-compression refrigeration system
DE3741509A1 (de) * 1987-12-08 1989-06-22 Hoechst Ag Verfahren zur herstellung optisch aktiver 3-desmethylmevalonsaeurederivate sowie zwischenprodukte
DE69329221D1 (de) 1992-06-10 2000-09-21 Chisso Corp Optisch aktives, 1,5-disubstituiertes 2,4-0-Isopropyliden-2,4-dihydroxypentan und ein Verfahren zu seiner Herstellung
ES2106926T3 (es) * 1992-07-02 1997-11-16 Hoechst Ag Procedimiento para la preparacion del ester terc-butilico del acido (3r,5s)6-hidroxi-3,5-o-isopropiliden-3,5-dihidroxi-hexanoico.
KR950005791A (ko) * 1993-08-09 1995-03-20 후꾸야마 마사루 카르복실산 에스테르-유도체의 제조방법 및 그 방법에 사용되는 4- 플루오로비페닐 유도체
TR199900191T2 (xx) * 1996-07-29 1999-04-21 Warner-Lambert Company (S)-3,4-Dihidroksibutirik asitin korumal� esterlerinin sentezi i�in geli�tirilmi� proses.
JPH11171850A (ja) * 1997-12-12 1999-06-29 Kanegafuchi Chem Ind Co Ltd 酪酸エステル誘導体の製造方法
AU2000254249A1 (en) * 2000-03-28 2001-10-08 Biocon India Limited Synthesis of (r-(r*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-
WO2002057229A1 (en) 2001-01-19 2002-07-25 Biocon India Limited FORM V CRYSTALLINE [R-(R*,R*)]-2-(4-FLUOROPHENYL)-ß,$G(D)-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1- HEPTANOIC ACID HEMI CALCIUM SALT. (ATORVASTATIN)
BR0215602A (pt) 2002-02-25 2004-12-07 Biocon Ltd ésteres de boronato

Also Published As

Publication number Publication date
JP4139334B2 (ja) 2008-08-27
JP2005518427A (ja) 2005-06-23
HUP0500125A3 (en) 2008-03-28
NO20043223L (no) 2004-09-28
CZ2004863A3 (cs) 2004-12-15
CA2475586A1 (en) 2003-08-28
RO122095B1 (ro) 2008-12-30
ES2332881T3 (es) 2010-02-15
US20050154213A1 (en) 2005-07-14
AU2002241235A1 (en) 2003-09-09
DE60233899D1 (de) 2009-11-12
DK1478650T3 (da) 2010-01-25
AU2002241235B2 (en) 2009-04-23
EP1478650A4 (de) 2008-02-13
US20060040898A1 (en) 2006-02-23
HRP20040888B1 (en) 2012-12-31
HUP0500125A2 (hu) 2005-04-28
BR0215602A (pt) 2004-12-07
HRP20040888A2 (en) 2005-04-30
CA2475586C (en) 2011-07-05
EP1478650A1 (de) 2004-11-24
KR100598079B1 (ko) 2006-07-07
US7301046B2 (en) 2007-11-27
KR20040084915A (ko) 2004-10-06
SK288093B6 (sk) 2013-07-02
EP1478650B1 (de) 2009-09-30
IL163333A (en) 2009-05-04
US7238826B2 (en) 2007-07-03
NZ534688A (en) 2005-04-29
PT1478650E (pt) 2010-01-04
WO2003070733A1 (en) 2003-08-28
SK3052004A3 (sk) 2005-02-04

Similar Documents

Publication Publication Date Title
DK1578733T3 (da) Fremgangsmåde til fremstilling af rosuvastatin
CY1109006T1 (el) Παραγωγα πουρινης ως αναστολεις κινασης
ATE444299T1 (de) Neue boronatester
WO2012002741A3 (en) Process for the preparation of hmg-coa reductase inhibitors and intermediates thereof
DE60328028D1 (de) Imidazolverbindungen als inhibitoren des transformierenden wachstumsfaktors (twf)
NO20081636L (no) FAP - inhibitorer
ATE499097T1 (de) Monozyklische heterozyklen als kinase-hemmer
BRPI0413468A (pt) inibidores de hmg-coa redutase baseados em pirrol
AU2001230395A1 (en) Use of cox-2 inhibitors as gastroprokinetics
NO20043919L (no) Fremgangsmate for fremstilling av HMG-COA reduktaseinhiberende mevalonsyrederivater
EA200700702A1 (ru) Аналоги локсапина и способы их применения
EA200601678A1 (ru) Новые имидазолы
UY28653A1 (es) N-alquil pirroles como inhibidores de la hmg-coa reductasa
ATE496025T1 (de) Magnesiumsalze von hmg-coa-reduktase-hemmern
ATE482698T1 (de) Vermeidung von vorhofflimmern (af) mit der verwendung von statin
EA200800916A1 (ru) СПОСОБ СИНТЕЗА ИНГИБИТОРОВ HMG-CoA РЕДУКТАЗЫ
PE20070603A1 (es) COMPOSICION FARMACEUTICA QUE COMPRENDE UN INHIBIDOR DE ESCUALENO SINTASA Y UN INHIBIDOR DE 3-HIDROXI-3-METILGLUTARIL-CoA-REDUCTASA (HMG-CoA)
SE0301846D0 (sv) Use of certain compounds in treatment of obesity
EP1404313A4 (de) METHYL-ANALOGA VON SIMVASTATIN ALS NEUE HMG-CoA-REDUKTASE-HEMMER
EA200800411A1 (ru) Новая кристаллическая форма периндоприлэрбумина
CY1115453T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει ενα ανασταλτικο παραγοντα του ενζυμου ημg-cοα αναγαγασης και ενα ανασταλτικο παραγοντα του ενζυμου γαστρεντερικης λιπασης
AR048668A1 (es) Composiciones hipocolesterolemiantes y procedimiento para prepararlas
WO2011031964A3 (en) Inhibitors of biofilm formation
CO5611117A2 (es) Combinacion de compuestos organicos
ATE327749T1 (de) Hypoestoxide, derivate und agonisten davon zur verwendung bei der behandlung und prophylaxe von hyperlipidämie

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties